- Home
- INFU vs PRLD Comparison
INFU vs PRLD Comparison
Compare INFU & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INFU | PRLD |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.8M | 218.0M |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | INFU | PRLD |
|---|---|---|
| Price | $8.93 | $4.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $15.00 | $5.67 |
| AVG Volume (30 Days) | 196.5K | ★ 506.5K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | 23.21 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $143,436,000.00 | $12,140,000.00 |
| Revenue This Year | $3.20 | $320.10 |
| Revenue Next Year | $7.31 | $100.00 |
| P/E Ratio | $174.20 | ★ N/A |
| Revenue Growth | 6.36 | ★ 73.43 |
| 52 Week Low | $5.08 | $0.75 |
| 52 Week High | $11.04 | $5.54 |
Technical Indicators
Market Signals| Indicator | INFU | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 43.47 | 48.21 |
| Support Level | $8.64 | $1.09 |
| Resistance Level | $8.96 | $5.43 |
| Average True Range (ATR) | 0.53 | 0.52 |
| MACD | -0.15 | -0.09 |
| Stochastic Oscillator | 33.46 | 25.88 |
Price Performance
Historical ComparisonAbout INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.